• Gen9 Announces Appointment of Kevin Munnelly as President and CEO More...

• Brian Klein to Join Stifel Nicolaus' Healthcare Equity Research Team More...

• Lance Alstodt Joins Leerink Swann and Company More...

• Edmond de Rothschild Raises $152 Million for Its Fourth Life Sciences Fund More...

• Walvax Biotech Gains Majority Control of Fengmao Biotech More...

• Actinium Pharmaceuticals, Inc. Licenses Monoclonal Antibody From Fred Hutchinson Cancer Research Center More...

• Merck & Co., Inc. (MRK) Announces Collaboration to Improve Maternal Health through Expanded Access to Family Planning More...

• Research Corporation Technologies Partners with Isogenica Limited for Large Scale Screening of a New Antibody-Derived Scaffold Platform More...

• Baylor College of Medicine and Gradalis Inc. Enter Collaboration Agreement to Utilize Gradalis' Bifunctional shRNA Platform in Translational Medicine Research More...

• Echo Therapeutics Expands License Agreement with Ferndale Pharma More...

• Alexion Pharmaceuticals Inc. (ALXN) to Report Second Quarter 2012 Results on Wednesday, July 25, 2012 More...

• AmerisourceBergen Corporation (ABC) Announces Date and Time for Fiscal Third Quarter Earnings Release More...

• BioMarin Pharmaceutical Inc. (BMRN) to Host Second Quarter 2012 Financial Results Conference Call and Webcast on Wednesday, August 1 at 5:00 p.m. ET More...

• BioClinica, Inc. to Release Second Quarter 2012 Financial Results on August 8, 2012 More...

• Ironwood Pharmaceuticals to Host Second Quarter 2012 Investor Update Call More...

• AstraZeneca PLC (AZN) Loses Fight Over Generic Seroquel More...

• Teva Pharmaceutical Industries Limited (TEVA) Announces Favorable United Kingdom Court Ruling in COPAXONE® Patent Litigation Proceeding More...

• FDA Suspends Ipsen (IPN.PA)'s Ph3 Hemophilia Drug Study More...

• Eli Lilly and Company (LLY) Schizophrenia Drug Fails Late-stage Trial More...

• Blow for BioInvent (BOVNF) as Vascular Treatment Fails More...

• Eisai Inc. (ESALF.PK)'s Halavan Misses Endpoints in Phase III Trial More...

• GlaxoSmithKline (GSK), Shionogi & Co., Ltd. Say HIV Drug Beats Gilead Sciences, Inc. (GILD) Atripla in Test More...

• Links Medical Receives Both FDA & EU Market Clearance for Advance Wound Care Products With Medical-Grade Manuka Honey More...

• Hemispherx Biopharma (HEB) and the FDA Reach Agreement on Filing Requirements for the Company's Complete Response in Support of Ampligen® New Drug Application for Chronic Fatigue Syndrome Treatment More...

• 3 Drinks a Week Found to Cut Arthritis Risk by Half, Karolinska Institute Study More...

• U.S. Patients Get More Cancer Drugs Access, But Pay for Privilege, Tufts Center for the Study of Drug Development Study More...

• Food in Smaller Pieces May Help Control Weight, Arizona State University Study More...

• Quitting Smoking Packs on More Pounds Than Thought, University of Paris Study More...

• Early-Life Exposure to PCE, Chemical in Drinking Water, May Affect Vision,Boston University School of Public Health Study More...

• Oramed Pharmaceuticals Inc. (ORMP.OB) Granted 2nd Patent in New Zealand; 3rd Patent for Core Technology on Oral Delivery of Proteins More...

• NuPathe Inc. (PATH) Announces Allowance of Additional U.S. Patent Application for NP202 More...

• SCOLR Pharma, Inc. (DDD) Announces Issuance of European Patent for CDT&#0174 Ibuprofen More...

• Star Scientific , Inc. Announces Allowance of Patent Claims Covering Products for Weight Loss and Reduction in Tobacco Use More...

• U.S. Government Expands Population Eligible to Receive Bavarian Nordic (BAVA.CO)'s Smallpox Vaccine in an Emergency More...